Frequent BRAF gain in low-grade diffuse gliomas with 1p/19q loss

Brain Pathology

Volumn 22, Issue 6, 2012, Pages 834-840

  Kim, Young Ho ^a   Nonoguchi, Naosuke ^a   Paulus, Werner ^b   Brokinkel, Benjamin ^b   Keyvani, Kathy ^c   Sure, Ulrich ^c   Wrede, Karsten ^c   Mariani, Luigi ^d,e   Giangaspero, Felice ^f,g   Tanaka, Yuko ^h   Nakazato, Yoichi ^h   Vital, Anne ⁱ   Mittelbronn, Michel ^j   Perry, Arie ^k   Ohgaki, Hiroko ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e UNIVERSITY OF BERN   (Switzerland)

^f SAPIENZA UNIVERSITY OF ROME   (Italy)

^g IRCCS NEUROMED   (Italy)

^h GUNMA UNIVERSITY   (Japan)

ⁱ Bordeaux Institute of Neuroscience   (France)

^j UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^k UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

BRAF gain; BRAF KIAA1549 fusion gene; diffuse astrocytoma; oligodendroglioma

Indexed keywords

B RAF KINASE; COMPLEMENTARY DNA; PROTEIN P53;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CHILD; CHROMOSOME 19Q; CHROMOSOME 1P; CHROMOSOME LOSS; CONTROLLED STUDY; DISSEMINATED CANCER; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GAIN OF FUNCTION MUTATION; GENE FUSION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OLIGODENDROGLIOMA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; QUANTITATIVE ASSAY; STATISTICAL SIGNIFICANCE;

EID: 84867574820     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00601.x     Document Type: Article

References (34)

1. Bastian BC, LeBoit PE, Hamm H, Bröcker EB, Pinkel D, (1998) Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res 58: 2170-2175.
2. Basto D, Trovisco V, Lopes JM, Martins A, Pardal F, Soares P, Reis RM, (2005) Mutation analysis of B-RAF gene in human gliomas. Acta Neuropathol 109: 207-210.
3. Biernat W, Huang H, Yokoo H, Kleihues P, Ohgaki H, (2004) Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas. Brain Pathol 14: 131-136.
4. Brose MS, Volpe P, Feldman M, Kumar M, Rishi I, Gerrero R, et al, (2002) BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res 62: 6997-7000.
5. Camelo-Piragua S, Jansen M, Ganguly A, Kim JC, Cosper AK, Dias-Santagata D, et al, (2011) A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53. J Neuropathol Exp Neurol 70: 110-115.
6. Cantwell-Dorris ER, O'Leary JJ, Sheils OM, (2011) BRAFV600E: implications for carcinogenesis and molecular therapy. Mol Cancer Ther 10: 385-394.
7. Ciampi R, Nikiforov YE, (2005) Alterations of the BRAF gene in thyroid tumors. Endocr Pathol 16: 163-172.
8. Cohen Y, Xing M, Mambo E, Guo Z, Wu G, Trink B, et al, (2003) BRAF mutation in papillary thyroid carcinoma. J Natl Cancer Inst 95: 625-627.
9. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, et al, (2002) Mutations of the BRAF gene in human cancer. Nature 417: 949-954.
10. Greshock J, Nathanson K, Medina A, Ward MR, Herlyn M, Weber BL, Zaks TZ, (2009) Distinct patterns of DNA copy number alterations associate with BRAF mutations in melanomas and melanoma-derived cell lines. Genes Chromosomes Cancer 48: 419-428.
11. Horbinski C, Hamilton RL, Nikiforov Y, Pollack IF, (2010) Association of molecular alterations, including BRAF, with biology and outcome in pilocytic astrocytomas. Acta Neuropathol 119: 641-649.
12. Jacob K, Albrecht S, Sollier C, Faury D, Sader E, Montpetit A, et al, (2009) Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours. Br J Cancer 101: 722-733.
13. Jeuken J, van den Broecke C, Gijsen S, Boots-Sprenger S, Wesseling P, (2007) RAS/RAF pathway activation in gliomas: the result of copy number gains rather than activating mutations. Acta Neuropathol 114: 121-133.
14. Jones DT, Kocialkowski S, Liu L, Pearson DM, Backlund LM, Ichimura K, Collins VP, (2008) Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res 68: 8673-8677.
15. Karbowniczek M, Henske EP, (2005) The role of tuberin in cellular differentiation: are B-Raf and MAPK involved? Ann N Y Acad Sci 1059: 168-173.
16. Kim YH, Nobusawa S, Mittelbronn M, Paulus W, Brokinkel B, Keyvani K, et al, (2010) Molecular classification of low-grade diffuse gliomas. Am J Pathol 177: 2708-2714.
17. Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA, (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63: 1454-1457.
18. Korshunov A, Meyer J, Capper D, Christians A, Remke M, Witt H, et al, (2009) Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma. Acta Neuropathol 118: 401-405.
19. Krupp W, Geiger K, Schober R, Siegert G, Froster UG, (2004) Cytogenetic and molecular cytogenetic analyses in diffuse astrocytomas. Cancer Genet Cytogenet 153: 32-38.
20. Lawson AR, Tatevossian RG, Phipps KP, Picker SR, Michalski A, Sheer D, et al, (2010) RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort. Acta Neuropathol 120: 271-273.
21. Lin WM, Baker AC, Beroukhim R, Winckler W, Feng W, Marmion JM, et al, (2008) Modeling genomic diversity and tumor dependency in malignant melanoma. Cancer Res 68: 664-673.
22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, (eds) (2007) WHO Classification of Tumours of the Central Nervous System. IARC: Lyon.
23. Namba H, Nakashima M, Hayashi T, Hayashida N, Maeda S, Rogounovitch TI, et al, (2003) Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J Clin Endocrinol Metab 88: 4393-4397.
24. Nigro JM, Takahashi MA, Ginzinger DG, Law M, Passe S, Jenkins RB, Aldape K, (2001) Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 158: 1253-1262.
25. Pfister S, Janzarik WG, Remke M, Ernst A, Werft W, Becker N, et al, (2008) BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J Clin Invest 118: 1739-1749.
26. Ponchel F, Toomes C, Bransfield K, Leong FT, Douglas SH, Field SL, et al, (2003) Real-time PCR based on SYBR-Green I fluorescence: an alternative to the TaqMan assay for a relative quantification of gene rearrangements, gene amplifications and micro gene deletions. BMC Biotechnol 3: 18.
27. Pratilas CA, Solit DB, (2010) Targeting the mitogen-activated protein kinase pathway: physiological feedback and drug response. Clin Cancer Res 16: 3329-3334.
28. Satyamoorthy K, Li G, Gerrero MR, Brose MS, Volpe P, Weber BL, et al, (2003) Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res 63: 756-759.
29. Schiffman JD, Hodgson JG, VandenBerg SR, Flaherty P, Polley MY, Yu M, et al, (2010) Oncogenic BRAF mutation with CDKN2A inactivation is characteristic of a subset of pediatric malignant astrocytomas. Cancer Res 70: 512-519.
30. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, et al, (2011) Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma. Acta Neuropathol 121: 397-405.
31. Sievert AJ, Jackson EM, Gai X, Hakonarson H, Judkins AR, Resnick AC, et al, (2009) Duplication of 7q34 in pediatric low-grade astrocytomas detected by high-density single-nucleotide polymorphism-based genotype arrays results in a novel BRAF fusion gene. Brain Pathol 19: 449-458.
32. Tiacci E, Trifonov V, Schiavoni G, Holmes A, Kern W, Martelli MP, et al, (2011) BRAF mutations in hairy-cell leukemia. N Engl J Med 364: 2305-2315.
33. Tohma Y, Gratas C, Biernat W, Peraud A, Fukuda M, Yonekawa Y, et al, (1998) PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas. J Neuropathol Exp Neurol 57: 684-689.
34. Weissenborn SJ, Wieland U, Junk M, Pfister H, (2010) Quantification of beta-human papillomavirus DNA by real-time PCR. Nat Protoc 5: 1-13.